BioProduction by Sekisui offers contract development and manufacturing services tailored for the biopharmaceutical industry. With a facility in the UK that boasts over 40 years of large scale fermentation and purification experience, Sekisui demonstrates expertise in the scale-up and manufacturing of enzymes, plasmids, and other proteins essential for the production of biopharmaceuticals. Specialising as a biologics CDMO, the company focuses on microbial fermentation and purification. Currently, they are undergoing a $19M expansion of their cGMP facility for drug substance manufacturing, which is set to be completed in 2024.

Services include:
– Process Development
– Bioprocessing
– Contract Manufacturing (CMO)
– Manufacturing
– Downstream Processing
– Fermentation
– Lyophilization
– APIs (Active Pharmaceutical Ingredients)
– Biologics
– Microbial-based Therapeutic Proteins
– Proteins
– Microbial Fermentation
– Protein Extraction/Purification
– Raw Materials
– Technology Transfer
– Contract Development and Manufacturing (CDMO)

Sekisui is committed to providing comprehensive solutions in the biopharmaceutical sector, ensuring high-quality manufacturing and development services to meet industry demands. For further information, please visit bioproduction-sekisui.com.